Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial

被引：0

作者：

Naoto Katakami

Tomoya Mita

Hidenori Yoshii

Toshihiko Shiraiwa

Tetsuyuki Yasuda

Yosuke Okada

Keiichi Torimoto

Yutaka Umayahara

Hideaki Kaneto

Takeshi Osonoi

Tsunehiko Yamamoto

Nobuichi Kuribayashi

Kazuhisa Maeda

Hiroki Yokoyama

Keisuke Kosugi

Kentaro Ohtoshi

Isao Hayashi

Satoru Sumitani

Mamiko Tsugawa

Kayoko Ryomoto

Hideki Taki

Tadashi Nakamura

Satoshi Kawashima

Yasunori Sato

Hirotaka Watada

Iichiro Shimomura

机构：

[1] Osaka University Graduate School of Medicine,Department of Metabolic Medicine

[2] Osaka University Graduate School of Medicine,Department of Metabolism and Atherosclerosis

[3] Juntendo University Graduate School of Medicine,Department of Metabolism & Endocrinology

[4] Juntendo Tokyo Koto Geriatric Medical Center,Department of Medicine, Diabetology & Endocrinology

[5] Shiraiwa Medical Clinic,Department of Diabetes and Endocrinology

[6] Osaka Police Hospital,First Department of Internal Medicine, School of Medicine

[7] University of Occupational and Environmental Health,Department of Diabetes and Endocrinology

[8] Japan,Diabetes and Endocrinology

[9] Osaka General Medical Center,Center for Diabetes and Endocrinology

[10] Department of Diabetes,Department of Endocrinology and Metabolism

[11] Endocrinology and Metabolism,Center for Diabetes Mellitus

[12] Kawasaki Medical School,Diabetes Center

[13] Nakakinen Clinic,Department of Internal Medicine

[14] Kansai Rosai Hospital,Department of Preventive Medicine and Public Health

[15] Misaki Naika Clinic,undefined

[16] Kitasenri Maeda Clinic,undefined

[17] Jiyugaoka Medical Clinic,undefined

[18] Kosugi Medical Clinic,undefined

[19] Otoshi Medical Clinic,undefined

[20] Hayashi Clinic,undefined

[21] Nippon Life Hospital,undefined

[22] Ikeda Municipal Hospital,undefined

[23] Osaka Rosai Hospital,undefined

[24] National Hospital Organization Osaka National Hospital,undefined

[25] Kawasaki Hospital,undefined

[26] Kanda Naika Clinic,undefined

[27] Keio University School of Medicine,undefined

来源：

Cardiovascular Diabetology | / 20卷

关键词：

Arterial stiffness; Pulse wave velocity; Arteriosclerosis; Diabetes; SGLT2 inhibitor; Tofogliflozin;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

下载

共 50 条

[31] Empagliflozin versus Sitagliptin as add-on dual therapy in Egyptian patients with type 2 diabetes inadequately controlled with Metformin: a 12-week randomized, open-label, parallel-group trial
Haitham G. Zakaraia
Heba F. Salem
Mostafa A. A. Mostafa
Ahmed M. Ali
Hoda M. Rabea
Beni-Suef University Journal of Basic and Applied Sciences, 12
[32] Empagliflozin versus Sitagliptin as add-on dual therapy in Egyptian patients with type 2 diabetes inadequately controlled with Metformin: a 12-week randomized, open-label, parallel-group trial
Zakaraia, Haitham G.
Salem, Heba F.
Mostafa, Mostafa A. A.
Ali, Ahmed M.
Rabea, Hoda M.
BENI-SUEF UNIVERSITY JOURNAL OF BASIC AND APPLIED SCIENCES, 2023, 12 (01)
[33] Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multicenter Study
Otowa-Suematsu, Natsu
Sakaguchi, Kazuhiko
Nakamura, Tomoaki
Hara, Kenta
Kishi, Minoru
Hashimoto, Naoko
Yokota, Kazuki
Yoshino, Hiroshi
Kuroki, Yasuo
Nishiumi, Tomoko
Sou, Anna
Komada, Hisako
Okada, Yuko
Hirota, Yushi
Tamori, Yoshikazu
Ogawa, Wataru
DIABETES THERAPY, 2018, 9 (05) : 2067 - 2079
[34] Effect of switching from pioglitazone to the sodium glucose co-transporter-2 inhibitor dapagliflozin on body weight and metabolism-related factors in patients with type 2 diabetes mellitus: An open-label, prospective, randomized, parallel-group comparison trial
Cho, Kyu Yong
Nakamura, Akinobu
Omori, Kazuno
Takase, Takahiro
Miya, Aika
Manda, Naoki
Kurihara, Yoshio
Aoki, Shin
Atsumi, Tatsuya
Miyoshi, Hideaki
DIABETES OBESITY & METABOLISM, 2019, 21 (03): : 710 - 714
[35] Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial
Pavord, Ian D.
Holliday, Mark
Reddel, Helen K.
Braithwaite, Irene
Ebmeier, Stefan
Hancox, Robert J.
Harrison, Tim
Houghton, Claire
Oldfield, Karen
Papi, Alberto
Williams, Mathew
Weatherall, Mark
Beasley, Richard
LANCET RESPIRATORY MEDICINE, 2020, 8 (07): : 671 - 680
[36] CARDIOVASCULAR SAFETY OF DEGARELIX: RESULTS FROM A 12-MONTH, COMPARATIVE, RANDOMIZED, OPEN-LABEL, PARALLEL-GROUP PHASE III TRIAL IN PROSTATE CANCER PATIENTS
Klotz, Laurence
Smith, Matthew
Persson, Bo-Eric
Olesen, Tine Kold
Wilde, Arthur
JOURNAL OF UROLOGY, 2010, 183 (04): : E228 - E228
[37] Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder:: A randomized, open-label, 12-week, parallel-group trial
Han, Changsu
Pae, Chi-Un
Lee, Bun Hee
Ko, Young-Hoon
Masand, Prakash S.
Patkar, Ashwin A.
Jung, In-Kwa
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (02): : 437 - 444
[38] Correction: Empagliflozin versus Sitagliptin as add-on dual therapy in Egyptian patients with type 2 diabetes inadequately controlled with Metformin: a 12-week randomized, open-label, parallel-group trial
Haitham G. Zakaraia
Heba F. Salem
Mostafa A. A. Mostafa
Ahmed M. Ali
Hoda M. Rabea
Beni-Suef University Journal of Basic and Applied Sciences, 13
[39] Comparison of the Effectiveness of Once-Daily Alogliptin/Metformin and Twice-Daily Anagliptin/Metformin Combination Tablet in a Randomized, Parallel-Group, Open-Label Trial in Japanese Patients with Type 2 Diabetes
Shunsuke Yamazaki
Tatsuro Takano
Koji Tachibana
Soichiro Takeda
Yasuo Terauchi
Diabetes Therapy, 2022, 13 : 1559 - 1569
[40] Comparison of the Effectiveness of Once-Daily Alogliptin/Metformin and Twice-Daily Anagliptin/Metformin Combination Tablet in a Randomized, Parallel-Group, Open-Label Trial in Japanese Patients with Type 2 Diabetes
Yamazaki, Shunsuke
Takano, Tatsuro
Tachibana, Koji
Takeda, Soichiro
Terauchi, Yasuo
DIABETES THERAPY, 2022, 13 (08) : 1559 - 1569

← 1 2 3 4 5 →